SMTL ID : 6iuo.1

Crystal structure of FGFR4 kinase domain in complex with a covalent inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

monomer

Ligands

1 x AWX: N-({4-[4-amino-3-(3,5-dimethyl-1-benzofuran-2-yl)-7-oxo-6,7-dihydro-2H-pyrazolo[3,4-d]pyridazin-2-yl]phenyl}methyl)prop-2-enamide(Covalent)

AWX.1: 16 residues within 4Å: Chain A: L.42, C.46, Q.49, V.50, A.70, K.72, E.89, I.103, V.117, V.119, E.120, C.121, A.122, G.125, L.188, A.198 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:Q.49, A:V.50, A:K.72, A:V.119, A:V.119, A:L.188, A:A.198 Hydrogen bonds: A:E.120, A:A.122, A:A.122, A:G.125

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wang, Y. et al., Discovery and Development of a Series of Pyrazolo[3,4-d]pyridazinone Compounds as the Novel Covalent Fibroblast Growth Factor Receptor Inhibitors by the Rational Drug Design. J.Med.Chem. (2019)

Release Date

2019-10-23

Peptides

Fibroblast growth factor receptor 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Fibroblast growth factor receptor 4

Related Entries With Identical Sequence